-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Article source: Medical Rubik's Cube Info
Author: Sunshine
On December 9th, the CDE official website showed that the clinical trial of Aimefel IPG7236 tablets was approved for the treatment of solid tumors
CCR8 is a chemokine that is expressed both in most solid tumors and on tumor-associated regulatory T cells (TregII).
Preclinical studies have shown that IPG7236 can effectively block the infiltration and expansion of Treg II in the tumor microenvironment, reduce its immunosuppressive properties, have a broad-spectrum anti-tumor effect, and is extremely safe